XWELL INC
XWELNASDAQTrading Snapshot
- Day Range
- $0.92 – $0.94
- 52-Week Range
- $0.26 – $2.20
- Volume
- $2.01B
- Avg Volume
- $1.95B
- Shares Outstanding
- 8.4M
- Next Earnings
- Sep 17, 2026
Fundamentals Snapshot
- Annual Revenue
- $29M
- Last Q Revenue
- $7M
- P/E Ratio
- —
- P/S Ratio
- 0.3x
- EPS (TTM)
- $-3.66
- Dividend Yield
- —
Why Investors Own XWEL
- ✓High-growth profile — revenue up -7.5% YoY with expanding US Equity exposure.
- ✓Healthy economics — 42% gross margin and 9% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About XWELL INC
XWELL Inc. functions as a health and wellness services provider, primarily operating within airports. The company delivers its diverse offerings through various brands, including XpresSpa, XpresTest, Treat, and HyperPointe. Its core services feature a range of spa treatments such as massages, nail care, and skincare, further complemented by the sale of spa, travel, and general retail merchandise. Beyond relaxation services, XWELL also manages dedicated wellness centers. These facilities provide crucial health diagnostic services, encompassing COVID-19 screening and testing, rapid tests for various communicable diseases like influenza, RSV, and different flu strains (A&B), alongside seasonal flu vaccinations and other medical diagnostic procedures. To enhance accessibility for the traveling public, the company utilizes an integrated digital platform and a tailored retail selection. As of December 31, 2021, XWELL maintained a significant global presence, with 52 spa and clinic locations spanning 24 airports across the United States, the Netherlands, and the United Arab Emirates. The organization, headquartered in New York, New York, underwent a name change in October 2022, transitioning from its former identity as XpresSpa Group, Inc. to its current designation, XWELL Inc.
